Columbus, OH - May 2016
The Centers for Disease Control is now recommending that all pre-teens receive a 9-valent vaccine to protect against the human papillomavirus (HPV). While current HPV vaccines are effective, 9vHPV protects against the additional HPV strains that provides protection against up to 85 percent of cervical cancers and 90 percent of genital warts, as well as some types of anal, mouth and throat cancers.
“The vaccine is truly one of the most significant advances in preventative health care for this generation – and vaccinating your child against HPV is one of the most important things you can do as parent to reduce their risk of cancer” says Kate McCracken, MD, pediatric and adolescent gynecologist at Nationwide Children’s Hospital and assistant professor at The Ohio State University College of Medicine.
Is the HPV Vaccine Safe?
The HPV vaccine has been used by millions of people around the world for a decade. The FDA and CDC performed extensive safety testing before they approved the vaccine. As with any vaccine, there can be irritation, pain or swelling around the injection site.
Michael T. Brady, MD, an infectious disease specialist at Nationwide Children’s and associate editor of Red Book, an infectious disease reference from the American Academy of Pediatrics says, “Despite a number of claims about an association between HPV vaccine and serious health issues, such as ovarian failure, autoimmune diseases and deaths, these claims are not substantiated by the evidence. There is no conclusive evidence that HPV vaccine causes any serious health conditions.”
Who Should Receive the Vaccine?
The newest guidelines suggest that girls and boys receive a three-dose course of HPV vaccines starting at age 11 – but it can also be given well into young adulthood. Currently the vaccine is approved for young women from as early as age 9 through age 26 and young men from age 9 through age 21. It is just as important for boys to receive the vaccine as it is for girls.
New vs. Old Vaccine